What is ALPHAEON Corporation?
Headquartered in Newport Beach, California, ALPHAEON Corporation operates at the intersection of fintech and healthcare services. By providing comprehensive credit information and structured payment plans, the company enables medical and dental practitioners to offer flexible financing options directly to their patient base. This model effectively lowers the barrier to entry for elective procedures, thereby increasing patient conversion rates for providers while simultaneously managing the financial risk associated with medical credit. As a division of Strathspey Crown, ALPHAEON leverages deep industry expertise to navigate the complexities of healthcare reimbursement and consumer lending, maintaining a distinct competitive advantage in the specialized medical financing market.
How much funding has ALPHAEON Corporation raised?
ALPHAEON Corporation has raised a total of $107.4M across 4 funding rounds:
Series A
$27M
Series B
$80M
Debt
$150K
Debt
$233K
Series A (2015): $27M with participation from Longitude Capital Management Co., LLC
Series B (2015): $80M led by Longitude Capital, H&S Ventures, Chow Tai Fook Enterprises, and Sailing Capital
Debt (2020): $150K supported by PPP
Debt (2021): $233K featuring PPP
Key Investors in ALPHAEON Corporation
Longitude Capital
Longitude Capital is a healthcare focused venture capital firm that invests in biotechnology, medical technology and health solutions companies, pairing sector expertise, flexible capital and active partnership to help innovators scale and improve patient care.
Sailing Capital
Sailing Capital is a Shanghai and Hong Kong based global private equity firm that invests in market leaders across healthcare, technology, and consumer sectors, facilitating cross-border capital movement.
Chow Tai Fook Enterprises
Chow Tai Fook Enterprises is a diversified investment holding company with a significant global footprint, focusing on long-term value creation across various industries including healthcare and infrastructure.
What's next for ALPHAEON Corporation?
The recent influx of capital positions ALPHAEON Corporation to scale its enterprise-level operations and enhance its digital infrastructure. By prioritizing the integration of seamless credit approval workflows, the company aims to further penetrate the elective care market. Future strategic initiatives will likely focus on diversifying its lending portfolio and strengthening partnerships with large-scale medical networks. As the demand for accessible healthcare financing continues to rise, ALPHAEON is well-positioned to leverage its established credit frameworks to capture additional market share, ensuring that both providers and patients benefit from streamlined financial solutions that facilitate high-quality medical outcomes.
See full ALPHAEON Corporation company page
